Results 131 to 140 of about 1,602,944 (312)
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Alternative assessment of computer numerical control (CNC) machine tool students [PDF]
, 1999 Plan BVocational Education curriculum is constantly in a state of flux due to the ever changing technological workplace. Traditional assessment methods are challenged to accurately assess the adult learners returning to post-secondary education. Industry
Quesada, Robert E.
core
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Developing and implementing a radiotherapy research activity assessment tool
, 2015 Purpose/Objective: Cancer research in the National Health Service (NHS) has increased by 10.5% in three years since the formation of the National Cancer Research (NCRN) networks in 2000.
Goldsworthy, Simon +4 more
core
Molecular Oncology, EarlyView.A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Research progress on assessment tools for mouth neoplasms patent⁃reported outcome
Huli yanjiu, 2019 This paper analyzed assessment tools for oral cancer patients⁃reported outcome,reviewed the research status of the patient-reported outcome scale and intended to provide theoretical basis for China’s oral cancer patient⁃reported outcome scale.
GUO Qian, LI Li, HOU Lili
doaj
Self Assessment Tool for Medical Exam Candidates
reservedStudents' knowledge assessment, particularly by oral examinations, is a resource-consuming process classically requiring human experts. This thesis investigates the development of a self-assessment tool aiming at making possible the automated ...
DEHGHAN, ALIREZA
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Molecular Oncology, EarlyView.Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source